NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Elkedonia

Elkedonia

Private
StrasbourgHealthcare & Life Scienceshttps://elkedonia.com/

Last Round

Seed

Jun 11, 2025

Total Funding Raised

$12.9M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Elkedonia is a drug discovery company that develops neuroplastogen therapies for treatment-resistant depression and other neuropsychiatric disorders.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Mental Health, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

neuroplastogen therapiesElk1 inhibitortreatment-resistant depressionTRDsmall molecule drug discoveryfirst-in-class therapypsychedelic alternativeketamine alternativenext-gen antidepressantspreclinical biotechpharma licensingprecision psychiatrycompanion biomarkersneuropsychiatric disorderspost-traumatic stress disorderPTSD

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Elkedonia Comps

Public and private peers based on sector, stage, and business model.

Elkedonia comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Elkedonia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 11, 2025
View all Funding Rounds

Key People

Founding team and executive leadership

Delphine Charvin

CEO and co-Founder

Founding Team

Sarah Delbaere

Chief Financial Officer

Executive Team

Elkedonia Investors

Notable investors and investment history

Elkedonia investors
InvestorRounds
Angelini VenturesSeed
Capital Grand EstSeed
CARMA FUNDSeed
SambrinvestSeed
Kurma PartnersSeed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 22, 2026

    Grew 43% QoQ, from 7 to 10 employees.

  • May 12, 2026

    Monthly visitors increased 41% MoM, from 663 to 937.

View all signals

Elkedonia Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Elkedonia Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Elkedonia's valuation, stock price, and market status.

Firmographic Details

HeadquartersStrasbourg
Employee Range10
Year Founded2025
Last FundingJun 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.